Improved neuroprotective effects of resveratrol-loaded polysorbate 80-coated poly(lactide) nanoparticles in MPTP-induced Parkinsonism
出版年份 2015 全文链接
标题
Improved neuroprotective effects of resveratrol-loaded polysorbate 80-coated poly(lactide) nanoparticles in MPTP-induced Parkinsonism
作者
关键词
-
出版物
Nanomedicine
Volume 10, Issue 7, Pages 1127-1138
出版商
Future Medicine Ltd
发表日期
2015-05-01
DOI
10.2217/nnm.14.165
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Mitochondria-targeted antioxidants for treatment of Parkinson's disease: Preclinical and clinical outcomes
- (2013) Huajun Jin et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Resveratrol: New Avenues for a Natural Compound in Neuroprotection
- (2013) Mercè Pallàs et al. CURRENT PHARMACEUTICAL DESIGN
- Antioxidant effects of resveratrol in cardiovascular, cerebral and metabolic diseases
- (2013) Albino Carrizzo et al. FOOD AND CHEMICAL TOXICOLOGY
- The impact of reactive oxygen species and genetic mitochondrial mutations in Parkinson's disease
- (2013) Li Zuo et al. GENE
- Lipid-Core Nanocapsules Improve the Effects of Resveratrol Against Aβ-Induced Neuroinflammation
- (2013) Rudimar L. Frozza et al. Journal of Biomedical Nanotechnology
- Neuroprotective Effects of Resveratrol Against Aβ Administration in Rats are Improved by Lipid-Core Nanocapsules
- (2013) Rudimar L. Frozza et al. MOLECULAR NEUROBIOLOGY
- Neuroprotective effects of agmatine in mice infused with a single intranasal administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)
- (2012) Filipe C. Matheus et al. BEHAVIOURAL BRAIN RESEARCH
- Lithium and valproate prevent olfactory discrimination and short-term memory impairments in the intranasal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) rat model of Parkinson's disease
- (2012) Adalberto A. Castro et al. BEHAVIOURAL BRAIN RESEARCH
- Role of Resveratrol and its Analogues in the Treatment of Neurodegenerative Diseases: Focus on Recent Discoveries
- (2012) V. Foti Cuzzola et al. CNS & Neurological Disorders-Drug Targets
- Pharmacokinetics of curcumin-loaded PLGA and PLGA–PEG blend nanoparticles after oral administration in rats
- (2012) Najeh Maissar Khalil et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Olfactory dysfunction in Parkinson disease
- (2012) Richard L. Doty Nature Reviews Neurology
- The Intranasal Administration of 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP): A New Rodent Model to Test Palliative and Neuroprotective Agents for Parkinson's disease
- (2011) Rui D. S. Prediger et al. CURRENT PHARMACEUTICAL DESIGN
- Administration of resveratrol: What formulation solutions to bioavailability limitations?
- (2011) A. Amri et al. JOURNAL OF CONTROLLED RELEASE
- Transport of drugs across the blood–brain barrier by nanoparticles
- (2011) Stefanie Wohlfart et al. JOURNAL OF CONTROLLED RELEASE
- Resveratrol attenuates 6-hydroxydopamine-induced oxidative damage and dopamine depletion in rat model of Parkinson's disease
- (2010) Mohd.Moshahid Khan et al. BRAIN RESEARCH
- Intranasal delivery of zidovudine by PLA and PLA–PEG blend nanoparticles
- (2010) Rubiana Mara Mainardes et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Proanthocyanidin-rich fraction from Croton celtidifolius Baill confers neuroprotection in the intranasal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine rat model of Parkinson’s disease
- (2010) Eduardo L. G. Moreira et al. JOURNAL OF NEURAL TRANSMISSION
- Risk is in the Air
- (2009) Rui D. S. Prediger et al. Annals of the New York Academy of Sciences
- Improvements of cellular stress response on resveratrol in liposomes
- (2009) Julijana Kristl et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Drug delivery to the brain using surfactant-coated poly(lactide-co-glycolide) nanoparticles: Influence of the formulation parameters
- (2009) Svetlana Gelperina et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- The SIRT1 activator resveratrol protects SK-N-BE cells from oxidative stress and against toxicity caused by α-synuclein or amyloid-β (1-42) peptide
- (2009) Diego Albani et al. JOURNAL OF NEUROCHEMISTRY
- Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment
- (2009) K Ray Chaudhuri et al. LANCET NEUROLOGY
- Single Intranasal Administration of 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine in C57BL/6 Mice Models Early Preclinical Phase of Parkinson’s Disease
- (2009) Rui D. S. Prediger et al. NEUROTOXICITY RESEARCH
- Neuroprotective effect of resveratrol on 6-OHDA-induced Parkinson's disease in rats
- (2008) Feng Jin et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Complexation of resveratrol with cyclodextrins: Solubility and antioxidant activity
- (2008) Zhong Lu et al. FOOD CHEMISTRY
- Neuroprotective Effects of Resveratrol on MPTP-Induced Neuron Loss Mediated by Free Radical Scavenging
- (2008) Kwok-Tung Lu et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- Neurobiology and treatment of Parkinson's disease
- (2008) Anthony H.V. Schapira TRENDS IN PHARMACOLOGICAL SCIENCES
- Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis
- (2008) Claire Henchcliffe et al. Nature clinical practice. Neurology
- Disease-modifying drugs and Parkinson's disease
- (2007) Hervé Allain et al. PROGRESS IN NEUROBIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started